Open AccessTherapy-related myeloid leukemia during erlotinib treatment in a non-small cell lung cancer patient: A case report
Author(s) -
So-My Koo,
Ki-Up Kim,
Yang-Ki Kim,
SooTaek Uh
Publication year - 2021
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v9.i24.7205
Subject(s) - medicine , erlotinib , myeloid leukemia , lung cancer , oncology , leukemia , cancer , erlotinib hydrochloride , epidermal growth factor receptor
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are tolerable drugs used for patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC). Serious adverse reactions are uncommon compared with cytotoxic drugs.